RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ALK-Abello A/S Stock

ALK-Abello A/S ROE 2024

ALK-Abello A/S ROE

0.11

Ticker

ALK B.CO

ISIN

DK0060027142

WKN

A0H0J1

In 2024, ALK-Abello A/S's return on equity (ROE) was 0.11, a 30.1% increase from the 0.08 ROE in the previous year.

ALK-Abello A/S Aktienanalyse

What does ALK-Abello A/S do?

ALK-Abello A/S is a Danish company specializing in the production of allergy-based products and therapies. It was founded in 1923 by Dr. H. C. Harald Petersen and is headquartered in Hørsholm, Denmark. The company's history began with Dr. Petersen's discovery that allergens could be administered to trigger an immune reaction in a control system. He developed a therapy for hay fever using pollen extracts from grasses, flowers, and trees to desensitize the immune system to these allergens. In 1940, ALK introduced the first specific immunotherapy (SIT) for protection against pollen allergies. ALK-Abello A/S is a leading provider of allergen-based therapeutics and diagnostic tests for allergic diseases. The company offers two main products: allergen immunotherapies and diagnostic tests for allergic diseases. These products are offered in 28 countries worldwide, and the company is the largest provider of allergen-based therapeutics in Europe. ALK-Abello A/S operates three main divisions: allergen immunotherapies, diagnostic products, and other specialty products. The allergen immunotherapies are based on allergen extracts and aim to train the immune system to tolerate allergens by administering a small amount that is enough to trigger an immune response but not cause an allergic reaction. These therapies are used for various allergic diseases, including hay fever, asthma, and allergic skin conditions. The diagnostic products of ALK-Abello A/S are used for the diagnosis of allergic diseases. There are different types of diagnostic tests, including skin tests, in vitro diagnostic tests, and specific IgE tests (blood tests). Other specialty products of ALK-Abello A/S include products for the treatment of specific allergies or diseases related to allergies. Examples include adrenaline auto-injectors for the treatment of anaphylactic shock and nasal sprays for the treatment of hay fever. In summary, ALK-Abello A/S is a leading provider of allergy products and therapies, with a long history in the development of allergen-based therapeutics. The company operates three main divisions and offers a wide range of products that can be used for the diagnosis and treatment of allergic diseases. ALK-Abello A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding ALK-Abello A/S's Return on Equity (ROE)

ALK-Abello A/S's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing ALK-Abello A/S's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

ALK-Abello A/S's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in ALK-Abello A/S’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about ALK-Abello A/S stock

What is the ROE (Return on Equity) of ALK-Abello A/S this year?

The ROE of ALK-Abello A/S this year is 0.11 undefined.

How has the Return on Equity (ROE) of ALK-Abello A/S developed compared to the previous year?

The ROE of ALK-Abello A/S has increased by 30.1% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of ALK-Abello A/S?

A high ROE indicates that ALK-Abello A/S generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of ALK-Abello A/S?

A low ROE can indicate that ALK-Abello A/S is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of ALK-Abello A/S affect the company?

A change in ROE (Return on Equity) of ALK-Abello A/S can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of ALK-Abello A/S?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of ALK-Abello A/S?

Some factors that can influence ALK-Abello A/S's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does ALK-Abello A/S pay?

Over the past 12 months, ALK-Abello A/S paid a dividend of 5 DKK . This corresponds to a dividend yield of about 3.12 %. For the coming 12 months, ALK-Abello A/S is expected to pay a dividend of 12.69 DKK.

What is the dividend yield of ALK-Abello A/S?

The current dividend yield of ALK-Abello A/S is 3.12 %.

When does ALK-Abello A/S pay dividends?

ALK-Abello A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of ALK-Abello A/S?

ALK-Abello A/S paid dividends every year for the past 6 years.

What is the dividend of ALK-Abello A/S?

For the upcoming 12 months, dividends amounting to 12.69 DKK are expected. This corresponds to a dividend yield of 7.92 %.

In which sector is ALK-Abello A/S located?

ALK-Abello A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von ALK-Abello A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ALK-Abello A/S from 3/20/2017 amounting to 5 DKK, you needed to have the stock in your portfolio before the ex-date on 3/16/2017.

When did ALK-Abello A/S pay the last dividend?

The last dividend was paid out on 3/20/2017.

What was the dividend of ALK-Abello A/S in the year 2023?

In the year 2023, ALK-Abello A/S distributed 0 DKK as dividends.

In which currency does ALK-Abello A/S pay out the dividend?

The dividends of ALK-Abello A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ALK-Abello A/S

Our stock analysis for ALK-Abello A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ALK-Abello A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.